A new Era of Personalized Medicine for Cystic Fibrosis – at Last! by Bradley S Quon, Pearce G Wilcox

Get full text

Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis. by Bradley S Quon, David A Ngan, Pearce G Wilcox, S F Paul Man, Don D Sin

Get full text

Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations. by Ashutosh Sharma, Gordon Kirkpatrick, Virginia Chen, Kate Skolnik, Zsuzsanna Hollander, Pearce Wilcox, Bradley S Quon

Get full text

Optic Disc Swelling and Vision Loss in a Patient with Cystic Fibrosis and Diabetes by Ioulia Iosfina, Jean Y. Chuo, Derek V. Godinho, Pearce G. Wilcox, Stuart H. Kreisman, Bradley S. Quon

Get full text

A Multicenter Retrospective Study Evaluating IL-5-Targeted Biologic Therapies for the Treatment of Asthma and Allergic Bronchopulmonary Aspergillosis in Adults With Cystic Fibrosis... by Sameer Desai, PhD, Sophia Shen, MD, Zosia Gryz, BSc, Elizabeth Tullis, MD, Anne L. Stephenson, MD, PhD, Bradley S. Quon, MD, MSc

Get full text

Validating the Data Completeness and Accuracy of the Canadian Cystic Fibrosis Registry by Ranjani Somayaji, Stephanie Y. Cheng, Noma Abdulrahem, Sanja Stanojevic, Paul Eckford, Bradley S. Quon, Elizabeth Cromwell, Albert Faro, Christopher H. Goss, Anne L. Stephenson

Get full text

Time to replace the oral glucose tolerance test for cystic fibrosis related diabetes first-step screening? Establishing glycemic tools relevant to cystic fibrosis by Mathew P. Estey, Shelby Sissons, Heather Sharpe, Michelle Doll-Shankaruk, Dan Beriault, Julie Gilmour, Kathleen Lee, Winnie Leung, Michael D. Parkins, Bradley S. Quon, Elizabeth Tullis, Jie Zheng, Grace Y. Lam

Get full text